Adverse effects after Ayahuasca administration in the clinical setting [Carta] (2022)
- Authors:
- USP affiliated authors: OSORIO, FLAVIA DE LIMA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; ROCHA, JULIANA MENDES - FMRP ; ROSSI, GIORDANO NOVAK - FMRP
- Unidade: FMRP
- DOI: 10.1097/JCP.0000000000001536
- Subjects: FÁRMACOS (SISTEMA NERVOSO CENTRAL); PLANTAS ALUCINÓGENAS; ALUCINOGÊNICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2022
- Source:
- Título: Journal of Clinical Psychopharmacology
- ISSN: 1533-712X
- Volume/Número/Paginação/Ano: v. 42, n. 3, p. 321-324, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ROCHA, Juliana Mendes et al. Adverse effects after Ayahuasca administration in the clinical setting [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/JCP.0000000000001536. Acesso em: 27 dez. 2025. , 2022 -
APA
Rocha, J. M., Rossi, G. N., Osório, F. de L., Hallak, J. E. C., & Santos, R. G. dos. (2022). Adverse effects after Ayahuasca administration in the clinical setting [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1097/JCP.0000000000001536 -
NLM
Rocha JM, Rossi GN, Osório F de L, Hallak JEC, Santos RG dos. Adverse effects after Ayahuasca administration in the clinical setting [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2022 ; 42( 3): 321-324.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1097/JCP.0000000000001536 -
Vancouver
Rocha JM, Rossi GN, Osório F de L, Hallak JEC, Santos RG dos. Adverse effects after Ayahuasca administration in the clinical setting [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2022 ; 42( 3): 321-324.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1097/JCP.0000000000001536 - Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Can hallucinogens alter personality functioning?: results of a clinical trial involving the Pfister’s Colors Pyramids test
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
- The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges
- Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: a transcultural study
- Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies
- The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020)
- Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach
- The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
- Multifaceted Empathy Test (MET): validity evidence for the Brazilian population concerning the computer-based (face-to-face) and online versions
Informações sobre o DOI: 10.1097/JCP.0000000000001536 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003113622.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
